Having found a reliable supplier in the United Arab Emirates, the Client entered into a supply contract with him and started working. The business was looking well batch after batch. But suddenly, like a bolt out of the blue, the Nikolaev customs says: «The cost of this equipment seems to be underestimated.
If we meter such equipment and weigh it, it turns out that its average price per meter or kilogram is higher. Therefore, the customs rendered a decision to adjust the customs value, thus the customs value of the equipment was tripled, and accordingly, the customs duties for its customs clearance should be paid three times as much.
While all this was going on, the delivery vehicles could not move anywhere, the standing and storage fee was charging extra and the buyers anxiously were awaiting their delayed goods. Who we are. Areas of Focus Cutting-edge biotechnology centered on antibody engineering technology. Discover our medicines. Get to Know Us Learn more about Kyowa Kirin and how we combine our values and core competencies to make a difference in our patient health and the society we live in.
At a Glance We help patients to live better lives, using the power of innovation in life-sciences and technologies. Commitment To Life move to page. In order for those of us at Kyowa Kirin Asia Pacific to meet the goals of our extraordinary mission to improve human health, we are continually looking for the very best and brightest to join in our efforts.
If who we are and what we do resonates with you, then click on the link below for a listing of current vacancies. We use cookie to improve your experience on our website. Growing with us At Kyowa Kirin Asia Pacific we believe that every patient is entitled to lead a quality life.
Don't just make medicine. Make people smile, bring light to their lives. We never forget our purpose and our core value of Commitment to Life. To grow we need the best people People who are passionate about making a real difference and never settle for the status quo. Discover our philosophy.
0コメント